Medication info
Rabeplus Tablets 20mg (Rabeprazole Sodium)

Rabeplus Tablets 20mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging × 2)
Approval status
Active

MFDS item code 201601060 · Approved 2016.02.26 · Insurance code 642706710

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms have resolved, subsequent symptoms may be controlled, if needed, with on-demand therapy using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.
Child dose
○ Children Safety in children has not been established.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastric ulcers and duodenal ulcers, and to alleviate the symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also suitable for long-term maintenance therapy of gastroesophageal reflux disease. For patients with gastrointestinal ulcers infected with Helicobacter pylori, it is used in combination with antibiotics to enhance therapeutic efficacy. It is effective in treating Zollinger-Ellison syndrome. It helps treat or improve symptoms of these various conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms have resolved, subsequent symptoms may be controlled, if needed, with on-demand therapy using 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution, as hepatic function is often reduced.

Child dose

○ Children Safety in children has not been established.

Precautions

This medication should not be used in patients who are allergic to this medication or its components or have had hypersensitivity reactions. Additionally, it is recommended not to administer it to patients taking certain antibiotics or other medications, or to pregnant or breastfeeding women for safety precautions. Patients with compromised liver function, elderly individuals, or those with a history of drug allergies should be particularly careful when using this medication. If symptoms of an allergy such as rash, hives, or itching occur during treatment, the medication should be discontinued immediately. Regular blood tests and liver function tests should be conducted, and if any abnormal symptoms are noted, the doctor should be consulted for appropriate actions. Various side effects may occur in different areas including heart, gastrointestinal, nervous, respiratory, and skin, so symptoms should be closely monitored. Caution is particularly necessary for increased fracture risk with long-term use of this medication. This medication can interact with other drugs, so it is essential to inform the doctor or pharmacist of any medications being taken. It is safer not to use this medication during pregnancy or breastfeeding. Caution is required as drowsiness may occur while driving or operating machinery. This medication should not be chewed or crushed and must be swallowed whole; it should be stored out of reach of children. If this medication is to be used long-term, it is important to regularly check the health status through examinations.

Side effects

rash, hives, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neuroexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, flaccidity of limbs, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, aspiration pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal visual field, tinnitus, otitis media, corneal opacity, blurred vision, diplopia, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary difficulties, kidney stones, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, total cholesterol elevation, triglyceride elevation, BUN elevation, elevation of serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, cervical stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevation of thyroid-stimulating hormone, skin lupus erythematosus, systemic lupus erythematosus, halitosis, dry mouth, increased intraocular pressure, palpitations, facial edema, flushing, paresthesia in hands and feet, allergic reaction, chest tightness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should definitely be stored in a sealed container. The recommended storage temperature is between 1 degree Celsius and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.